Product Reports Resources Pricing Login Book a demo

Metabolon

Biotech & Life Sciences · Morrisville, United States · Founded 2000

Provides actionable biological insights to answer the toughest questions in life sciences research and drug development MoreLess

Metabolon, Inc. specializes in providing advanced metabolomics solutions, which involve the large-scale study of small molecules called metabolites within cells, biofluids, tissues, or organisms. The company serves a diverse range of clients, including academic researchers, pharmaceutical companies, and government institutions. Operating in the biotechnology and life sciences market, Metabolon offers a comprehensive suite of services from study design and sample collection to data analysis and biological interpretation. The business model is service-based, generating revenue through contracts and collaborations for metabolomic analysis projects. Metabolon leverages its extensive compound library and integrated bioinformatics platform to deliver high-fidelity results, ensuring reliable and actionable insights for its clients. The company has successfully completed over 10,000 projects for more than 1,300 clients, demonstrating its expertise and reliability in the field.

Keywords: Metabolomics, Biotechnology, Data Analysis, Bioinformatics, Research, Pharmaceuticals, Academic, Government, Biological Insights, Compound Library.

Company overview

Metabolon company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2000
Headquarters
Morrisville, United States
Employees
202
Open positions
3
Dealroom signal
78.6
Investment activity
2 companies · latest Sep 2017
Capital deployed
Preferred round
ACQUISITION
client focusb2bsub industryBioTechnologysectorDiabetesbusiness modelManufacturingsectorTestingindustryHealthsectorBiotechnologysectorDrug DevelopmentsectorBiomarkerssectorPrecision MedicinesectorSpinoutsectorBiotech and PharmasectorHorizon Europesectormedical testing

Valuation & funding

Metabolon funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Jun 2024 $0 National Institutes of Health
DEBTDebt May 2024 $60M Trinity Capital
GRANTOther financing Dec 2023 $0 National Institutes of Health
LATE VCOther financing Jan 2023 $25M $100M Undisclosed
GROWTH EQUITY VCOther financing Sep 2020 $72M Perceptive Advisors · EW Healthcare Partners
DEBTDebt Aug 2018 Undisclosed
DEBTDebt Aug 2016 Essex Woodlands Health Ventures
EARLY VCOther financing Mar 2015 Undisclosed
SERIES EOther financing Jan 2014 Camden Partners
SERIES DOther financing Aug 2011 Fletcher Spaght Ventures · Global Crossroads Capital · Syngenta Ventures · Sevin Rosen Funds
Showing 10 recorded eventsUnlock the complete deal history →

Growth signals

Metabolon website traffic

Latest recorded traffic for Metabolon is 43K monthly website visits, up 59.3% over the last three months. Metabolon's team grew 2% over the past year.

Latest monthly visits43K 3-month web change+59.3% 1-year team growth+2%
Monthly website visits122 observations · Apr 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Metabolon compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
AtG TherapeuticsAt AtG, we develop novel classes of medicines and biomarkers to prevent cancer therapeutic resistance L'Hospitalet de Llobregat, Spain Operational 10 $616K $2.5M
OMINIOmini develops biosensing devices for immediate blood tests at the patient bedside Paris, France Operational
Scipher MedicineBringing precision medicine to complex diseases through the power of network medicine Waltham, United States Operational
DeepcellAims to provide detailed genetic health information through ordinary blood sampling Sunnyvale, United States Operational
Life lengthOffers a series of tests to measure cellular senescence, a crucial biological marker to establish biological age, for the early detection of chronic diseases and for risk stratification Madrid, Spain Operational
ProAxsisSpecialising in assay development for the capture, detection and measurement of active protease biomarkers of diseases Belfast, United Kingdom Operational
Sea4UsSea4Us is a biopharmaceutical startup specializing in discovering and developing new drugs, leveraging expertise in ion channels and marine biology Vila do Bispo, Portugal Operational
LuceroA Swedish biotech start-up that creates precision liquid handling solutions that help pharmaceutical companies use 3D cell cultures at scale Göteborgs Stad, Sweden Operational
Showing 8 of the closest matchesCompare every metric →

Talent graph

Metabolon's talent

Book a demo to see the people
Team profiled 33 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

14 investors on Metabolon's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
National Institutes of Health
Series A 3 investors entered at this stage
Aurora Funds
Sevin Rosen Funds
180 Degree Capital
Series B+ 9 investors entered at this stage
BDCA Venture
Fletcher Spaght Ventures
Global Crossroads Capital
Syngenta Ventures
Camden Partners
Essex Woodlands Health Ventures
Perceptive Advisors
EW Healthcare Partners
Trinity Capital
Other known 1 additional known investor
Duke University

Global footprint

Where Metabolon has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States81.4%
🇬🇧 United Kingdom6.2%
🇮🇪 Ireland5.6%
🇩🇪 Germany1.9%
🇪🇸 Spain1.2%
Top 5 of 9 shown

In the news

Latest news about Metabolon

Recent press, funding announcements, and product moves mentioning Metabolon — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Metabolon

An AI-synthesized read of the highest-engagement posts about Metabolon on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Metabolon’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.